Pfizer reaches agreement with YaoPharma for an anti-obesity pill
Pfizer CEO Albert Bourla speaks during a press conference with European Commission President Ursula von der Leyen after a visit…
Novo Nordisk A/S
Zealand Pharma unveils 2030 plan as weight loss competition heats up
Celsopupo | Stock | fake images Zealand Pharma outlined an ambitious five-year strategy for its anti-obesity portfolio on Thursday, highlighting…
Eli Lilly's weight-loss drug retatrutide clears first late-stage study
The Eli Lilly logo appears at the company's office in San Diego, California, USA, on November 21, 2025. Mike Blake…
Eli Lilly cuts cash prices on vials of weight-loss drug Zepbound
The Eli Lilly logo appears at the company's office in San Diego, California, USA, on November 21, 2025. Mike Blake…
Eli Lilly reaches $1 trillion market value, first for a healthcare company
A sign with the company's logo sits outside Eli Lilly's headquarters in Indianapolis, Indiana, on March 17, 2024. Scott Olson…
Novo Nordisk reduces Wegovy and Ozempic spot prices
Boxes of Ozempic and Wegovy manufactured by Novo Nordisk in a London pharmacy on March 8, 2024. Hollie Adams |…
Novo Nordisk pushes defense of its anti-obesity pill
A view shows a Novo Nordisk sign in front of its office in Bagsvaerd, outside Copenhagen, Denmark, July 14, 2025.…
Metsera considers that the new offer from Novo Nordisk is superior to that of Pfizer
The logos of Danish pharmaceutical company Novo Nordisk, maker of the successful diabetes and weight loss treatments Ozempic and Wegovy,…
Trump reaches agreement with Eli Lilly and Novo Nordisk
Wegovy injection pens laid out in Waterbury, Vermont, USA, on Monday, April 28, 2025. Shelby Knowles | Bloomberg | fake…
Trump negotiates with Lilly and Novo Nordisk could expand access to anti-obesity drugs
US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC on November…